Clinical Trial Update: Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enzalutamide in combination with androgen deprivation therapy and radiation therapy for high-risk localized prostate cancer; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

Sponsor: University of Sydney | Conditions: Prostatic Neoplasms | Phase 3 | Status: ACTIVE_NOT_RECRUITING